CVS Extends MiPet Range

quantex_packshot CVS has boosted its fast-growing own brand MiPet range with the addition of two new products. The first of the new arrivals is Endectrid, a broad-spectrum spot-on flea and worming product with licensed efficacy in dogs, cats and ferrets against a range of parasites, including lungworm. The second is Quantex, a worming tablet for dogs and cats, with licensed efficacy against tapeworm.

The MiPet range, offered to practices within the group and to members of its buying group, MiVetClub, already includes a range of 15 nutraceutical and pharmaceutical products with waiting room retail products and life stage pet food set to follow later this year.

Sara Armitage, Director of Product and Buying at CVS, explained:  “Offering an affordable, high quality own brand range, supported by our veterinary teams,  is an effective way for us to build loyalty to our practices and to manage the supply of products both to them and on to owners.  We are the first corporate group to offer an extensive own brand range and feedback has been very positive.  The MiPet range is also available to members of our buying group MiVetClub.

“We will continue to grow the range and expect to launch a number of additional products later this year.”

Key to its success is CVS’ ability to attract ambitious veterinary staff whilst continuing to invest in the development of their clinical skills and in research to drive the profession forward.  It also provides the business support to ensure its diverse range of small animal, large animal and equine practices achieve their full potential.   CVS’  guiding principles include a commitment to excellence in all aspects of its work and a focus on building long-term relationships with its customers and suppliers.  The company  works in close partnership with the wider veterinary profession and industry colleagues.